HealthEquity Inc.’s filing revealed that its PRESIDENT AND CEO Kessler Jon unloaded Company’s shares for reported $1.66 million on Jun 27. In the deal valued at $60.96 per share,27,230 shares were sold. As a result of this transaction, Kessler Jon now holds 3,875 shares worth roughly $ 0.26 million.
Then, Kessler Jon sold 19,588 shares, generating $1,177,660 in total proceeds. Upon selling the shares at $60.12, the PRESIDENT AND CEO now owns 6,129 shares.
Before that, Rosner Elimelech sold 10,156 shares. HealthEquity Inc. shares valued at $652,925 were divested by the EVP, CHIEF TECHNOLOGY OFFICER at a price of $64.29 per share. As a result of the transaction, Rosner Elimelech now holds 70,334 shares, worth roughly $4.7 million.
Goldman upgraded its HealthEquity Inc. [HQY] rating to a Neutral from a a Sell in a research note published on Tuesday, October 21, 2022; the price target was increased to $77 from $64. PT values the company’s stock at a premium of 13.19 to its Tuesday closing price.
Price Performance Review of HQY
On Tuesday, HealthEquity Inc. [NASDAQ:HQY] saw its stock jump 0.63% to $66.84. On the same session, the stock had its day’s lowest price of $65.18, but rose to a high of $67.75. Over the last five days, the stock has lost -1.62%. HealthEquity Inc. shares have risen nearly 8.44% since the year began. Nevertheless, the stocks have risen 1.72% over the past one year. While a 52-week high of $79.20 was reached on 08/03/23, a 52-week low of $48.86 was recorded on 05/04/23. SMA at 50 days reached $65.63, while 200 days put it at $61.36. A total of 0.88 million shares were traded, compared to the trading of 0.5 million shares in the previous session.
Levels Of Support And Resistance For HQY Stock
The 24-hour chart illustrates a support level at 65.43, which if violated will result in even more drops to 64.02. On the upside, there is a resistance level at 68.00. A further resistance level may holdings at 69.16. The Relative Strength Index (RSI) on the 14-day chart is 49.47, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.06%. Stochastics %K at 18.30% indicates the stock is a buying.
How much short interest is there in HealthEquity Inc.?
A steep rise in short interest was recorded in HealthEquity Inc. stocks on Aug 14, 2023, dropping by -0.3 million shares to a total of 3.31 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 3.61 million shares. There was a decline of -9.06%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 4.51% of the overall stock float, the days-to-cover ratio (short ratio) fell to 6.85.
HealthEquity Inc. [HQY] – Who Are The Largest Shareholders?
In filings from BlackRock Fund Advisors, it is revealed that the company now owns 9,201,562 shares, or roughly 10.77% of the outstanding HQY shares. In other words, the investor’s shares have risen by 151,422 from its previous 13-F filing of 9050140.0. Additionally, The Vanguard Group, Inc. increased 0.39% of its stake after which the total value it holdings stand at $560,962,304, while Wasatch Advisors, Inc. reduced -7.58% of its stake to hold $484.3 million in the firm. Over the last quarter, Fidelity Management & Research Co purchased 18,666 shares of HealthEquity Inc., while SSgA Funds Management, Inc. bought 65,809 shares. At present, William Blair Investment Manageme is holding 2,806,255 shares valued at $190.66 million. JPMorgan Investment Management, I owned 2,328,208 shares of the company at the time of its most recent 13F filing, worth $158.18 million.
According to FactSet, HealthEquity Inc.’s share price will average $81.92 in the next year, based on opinions of analysts polled by the firm. This is up nearly 21.95 percent from its previous closing price of $66.42. Analysts expect HealthEquity Inc. stock to reach the higher price of $94.00, while the lowest price estimate is $71.00. However, 13 analysts have rated HQY stock as a Buy in their predictions for 2023.